In the US, Ioversol (ioversol systemic) is a member of the drug class non-ionic iodinated contrast media and is used to treat Body Imaging, Cerebral Arteriography, Coronary Arteriography, Head Imaging, Intra-arterial Digital Subtraction Angiography, Intravenous Digital Subtraction Angiography, Intravenous Urography, Left Ventriculography, Pediatric Angiocardiography, Peripheral Arteriography, Renal Arteriography, Venography and Visceral Arteriography.
US matches:
- Ioversol
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
V08AB07
CAS registry number (Chemical Abstracts Service)
0087771-40-2
Chemical Formula
C18-H24-I3-N3-O9
Molecular Weight
807
Therapeutic Category
Contrast medium, radiography
Chemical Name
1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-5-[(hydroxyacetyl)(2-hydroxyethyl)amino]-2,4,6-triiodo-;
Foreign Names
- Ioversolum (Latin)
- Ioversol (German)
- Ioversol (French)
- Ioversol (Spanish)
Generic Names
- Ioversol (OS: DCF, USAN, BAN)
- MP 328 (IS: Mallinckrodt)
- Ioversol (PH: USP 32)
Brand Names
- Optiject
Codali, Belgium; Codali, Luxembourg; Guerbet, France - Optiray
Alfa Medisyst, Greece; Codali, Belgium; Codali, Luxembourg; Covidien, Austria; Covidien, Sweden; Covidien Nippon, Japan; Guerbet, Switzerland; Guerbet, France; Guerbet, Israel; Mallinckrodt, Argentina; Mallinckrodt, Australia; Mallinckrodt, United States; Nycomed, Serbia; Tyco, Canada; Tyco, Denmark; Tyco, Spain; Tyco, Finland; Tyco, Hungary; Tyco, Italy; Tyco, Norway; Zentiva, Czech Republic
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment